Info
Significant Ownership

Significant Ownership of Foresite Capital Fund VI LP

Signature - Title: /s/ James Tananbaum - James Tananbaum, Managing Member of the General Partner
Location: Larkspur, CA
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Foresite Capital Fund VI LP.

Notify me when Foresite Capital Fund VI LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Foresite Capital Fund VI LP

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
ALMS	Alumis Inc.	Common Stock	15.9%	$67.8M		15.2M	0%	James B. Tananbaum	May 21, 2025
RAPT	RAPT Therapeutics, Inc.	Common Stock	9.3%	$10.9M		12.5M		Foresite Capital Fund VI, L.P.	Dec 23, 2024
CASI	CASI Pharmaceuticals, Inc.	Ordinary Shares, par value $0.0001	6.3%	$1.63M	$320K	980K	+24.5%	Foresite Capital Fund VI LP	Sep 30, 2025
VSTM	Verastem, Inc.	Common Stock	5.1%	$27.7M		3.14M		Foresite Capital Fund VI LP	Oct 16, 2025
ENGN	enGene Holdings, Inc.	Common Shares, no par value	0%	$0		0		Foresite Capital Fund VI, L.P.	Sep 30, 2024

Schedules 13D/G Reported by Foresite Capital Fund VI LP:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Date Filed

* An asterisk sign (*) next to the price indicates that the price is likely invalid.